JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berlioz, F.
Right arrow Articles by Rozé, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berlioz, F.
Right arrow Articles by Rozé, C.

Vol. 294, Issue 2, 466-472, August 2000

alpha 2-Adrenergic Receptors Stimulate Oligopeptide Transport in a Human Intestinal Cell Line1

Françoise Berlioz , Jean-José Maoret, Hervé Paris, Marc Laburthe, Robert Farinotti and Claude Rozé

Institut National de la Santé et de la Recherche Médicale, Faculté X. Bichat, Paris (F.B., J.-J.M., M.L., C.R.); Institut National de la Santé et de la Recherche Médicale, Institut Louis Bugnard, Toulouse (H.P.); and Unité Propre de Recherches de I'Enseignement Supérieure, Faculté de Pharmacie, Chatenay-Malabry, France (F.B., R.F.)

Di- and tripeptides, as well as peptidomimetic drugs such as cephalexin (CFX), are absorbed by enterocytes via the oligopeptide transporter PepT1. We recently showed that the alpha 2-adrenergic agonist clonidine increases CFX absorption in anaesthetized rats. Herein, we investigated whether alpha 2-adrenergic receptors can directly affect PepT1 activity in a clone of the differentiated human intestinal cell line Caco-2 (Caco-2 3B) engineered to stably express alpha 2A-adrenergic receptors at a density similar to that found in normal mucosa. Measurement of CFX fluxes across cell monolayers cultured on transwell filters demonstrated that the alpha 2-agonists clonidine and UK14304 caused a 2-fold increase of CFX transport in Caco-2 3B cells, but not in Caco-2 (expressing PepT1 but not alpha 2-adrenergic receptors) or in the HT29 19A clone (expressing alpha 2-adrenergic receptors but not PepT1). The stimulatory effect of clonidine was abolished by glycyl-sarcosine (a competitor for the transporter) and blocked by yohimbine or RX821002 (alpha 2-antagonists). Analysis of the kinetics of CFX transport in control and clonidine-treated Caco-2 3B cells showed that clonidine increased Vmax of CFX transport without changing Km. Clonidine action was abolished by colchicine but not altered by amiloride, demonstrating that microtubule integrity but not Na+/H+ exchanger activity is necessary for the effect of alpha 2-agonists to occur. In conclusion, clonidine can directly activate alpha 2-adrenergic receptors located on epithelial cells. The precise molecular mechanisms whereby these receptors modulate PepT1 activity remain to be elucidated but an increased translocation to the apical membrane of preformed cytoplasmic transporter molecules is likely to be involved.

1 This study was funded in part by Institut de Recherches sur les Maladies de l'Appareil Digestif and by Association Charles Debray. F.B. was the recipient of a grant from the Fondation pour la Recherche Médicale.

0022-3565/00/2942-0466$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
P. Hindlet, A. Bado, R. Farinotti, and M. Buyse
Long-Term Effect of Leptin on H+-Coupled Peptide Cotransporter 1 Activity and Expression in Vivo: Evidence in Leptin-Deficient Mice
J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 192 - 201.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. Shimakura, T. Terada, H. Saito, T. Katsura, and K.-i. Inui
Induction of intestinal peptide transporter 1 expression during fasting is mediated via peroxisome proliferator-activated receptor {alpha}
Am J Physiol Gastrointest Liver Physiol, November 1, 2006; 291(5): G851 - G856.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. Shimakura, T. Terada, T. Katsura, and K.-I. Inui
Characterization of the human peptide transporter PEPT1 promoter: Sp1 functions as a basal transcriptional regulator of human PEPT1
Am J Physiol Gastrointest Liver Physiol, September 1, 2005; 289(3): G471 - G477.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. A. Adibi
Regulation of expression of the intestinal oligopeptide transporter (Pept-1) in health and disease
Am J Physiol Gastrointest Liver Physiol, November 1, 2003; 285(5): G779 - G788.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
X. Pan, T. Terada, M. Okuda, and K.-I. Inui
Altered Diurnal Rhythm of Intestinal Peptide Transporter by Fasting and Its Effects on the Pharmacokinetics of Ceftibuten
J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 626 - 632.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
H. Daniel and I. Rubio-Aliaga
An update on renal peptide transporters
Am J Physiol Renal Physiol, May 1, 2003; 284(5): F885 - F892.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
T. Matysiak-Budnik, M. Heyman, C. Candalh, D. Lethuaire, and F. Megraud
In vitro transfer of clarithromycin and amoxicillin across the epithelial barrier: effect of Helicobacter pylori
J. Antimicrob. Chemother., December 1, 2002; 50(6): 865 - 872.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
K. Ashida, T. Katsura, H. Motohashi, H. Saito, and K.-I. Inui
Thyroid hormone regulates the activity and expression of the peptide transporter PEPT1 in Caco-2 cells
Am J Physiol Gastrointest Liver Physiol, April 1, 2002; 282(4): G617 - G623.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.